OEM News

New Biogennix Wound Care Solutions Make Market Debut

When in contact with a wound, Agilon Surgical Matrix transforms into a gel, enveloping the entire affected area.

Author Image

By: Michael Barbella

Managing Editor

Biogennix has premiered its new Agilon Surgical Matrix wound care product.
 
Agilon Surgical Matrix is a wound care solution completely derived from bovine Type 1 collagen. Upon contact with a new or open wound—whether surgically or naturally occurring—Agilon Surgical Matrix transforms into a gel, enveloping the entire affected area. The coverage maintains a low pH wound environment that helps form tissue and epithelialization, which is conducive to successful wound healing.
 
Supported by in-vitro clinical performance data, Agilon Surgical Matrix demonstrates wide-ranging antimicrobial properties, offering added protection against infections. The product’s versatility extends to various surgical applications, serving as an alternative to close-suction drains, blood vessel ligation, or surgical site immobilization in preventing postoperative seromas.
 
With its sterile, single-use packaging, Agilon Surgical Matrix provides a safe and effective option for healthcare professionals and patients.
 
“Based on the feedback we’ve received from surgeons, we anticipate Agilon Surgical Matrix to be a significant addition to our product offering that will open the doors to a wide variety of indications,” Biogennix Business Development Vice President Greg Yocum said. “Because Agilon Surgical Matrix is purified low pH, bovine Type 1 collagen, it represents a significant advancement in surgical and post-operative care management, offering a myriad of benefits—including  antibacterial properties—which enhance patient outcomes and facilitate healing. This product also opens the door for Biogennix to participate in the wound care market.”

Agilon Surgical Matrix can be used to manage partial and full thickness wounds, pressure (stage I–IV) and venous ulcers, ulcers caused by mixed vascular etiologies, venous stasis and diabetic ulcers, first and second degree burns, cuts, abrasions, and surgical wounds. Surgical use areas include orthopedic, podiatry, cardiovascular, abdominal, neurologic, plastic/breast reconstruction, general, OB/GYN, trauma, vascular, burns, and ulcers.
 
Biogennix is an osteobiologics company based in Irvine, Calif., that develops, manufactures, and distributes advanced products for surgical procedures. 
 
 

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters